Jasper Therapeutics (JSPR) Competitors $2.43 +0.05 (+2.10%) Closing price 04:00 PM EasternExtended Trading$2.53 +0.10 (+4.12%) As of 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock JSPR vs. MDWD, FTLF, CRBU, BTMD, ACTU, BIOA, TVGN, KYTX, NVCT, and MCRBShould you be buying Jasper Therapeutics stock or one of its competitors? The main competitors of Jasper Therapeutics include MediWound (MDWD), FitLife Brands (FTLF), Caribou Biosciences (CRBU), biote (BTMD), Actuate Therapeutics (ACTU), BioAge Labs (BIOA), Tevogen Bio (TVGN), Kyverna Therapeutics (KYTX), Nuvectis Pharma (NVCT), and Seres Therapeutics (MCRB). These companies are all part of the "pharmaceutical products" industry. Jasper Therapeutics vs. Its Competitors MediWound FitLife Brands Caribou Biosciences biote Actuate Therapeutics BioAge Labs Tevogen Bio Kyverna Therapeutics Nuvectis Pharma Seres Therapeutics Jasper Therapeutics (NASDAQ:JSPR) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations. Which has higher valuation and earnings, JSPR or MDWD? MediWound has higher revenue and earnings than Jasper Therapeutics. MediWound is trading at a lower price-to-earnings ratio than Jasper Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/A-$71.27M-$6.01-0.40MediWound$20.22M9.14-$30.22M-$2.64-6.47 Is JSPR or MDWD more profitable? Jasper Therapeutics has a net margin of 0.00% compared to MediWound's net margin of -142.18%. MediWound's return on equity of -96.71% beat Jasper Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A -172.28% -128.34% MediWound -142.18%-96.71%-39.73% Does the media refer more to JSPR or MDWD? In the previous week, Jasper Therapeutics and Jasper Therapeutics both had 2 articles in the media. MediWound's average media sentiment score of 1.53 beat Jasper Therapeutics' score of 0.95 indicating that MediWound is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jasper Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MediWound 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk and volatility, JSPR or MDWD? Jasper Therapeutics has a beta of 2.77, indicating that its share price is 177% more volatile than the S&P 500. Comparatively, MediWound has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Do insiders and institutionals hold more shares of JSPR or MDWD? 79.9% of Jasper Therapeutics shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 4.6% of Jasper Therapeutics shares are held by insiders. Comparatively, 9.2% of MediWound shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer JSPR or MDWD? Jasper Therapeutics currently has a consensus target price of $28.75, suggesting a potential upside of 1,083.13%. MediWound has a consensus target price of $32.25, suggesting a potential upside of 88.71%. Given Jasper Therapeutics' higher probable upside, equities analysts clearly believe Jasper Therapeutics is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jasper Therapeutics 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60MediWound 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 SummaryMediWound beats Jasper Therapeutics on 8 of the 14 factors compared between the two stocks. Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JSPR vs. The Competition Export to ExcelMetricJasper TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.49M$3.09B$5.70B$10.27BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-0.4021.3075.8626.51Price / SalesN/A380.87491.12165.50Price / CashN/A44.4425.8129.89Price / Book0.599.6112.846.32Net Income-$71.27M-$53.28M$3.28B$270.51M7 Day Performance-6.18%0.32%0.22%2.15%1 Month Performance-21.86%4.59%4.61%6.35%1 Year Performance-89.41%9.24%68.33%25.49% Jasper Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JSPRJasper Therapeutics3.4585 of 5 stars$2.43+2.1%$28.75+1,083.1%-89.5%$39.49MN/A-0.4020MDWDMediWound1.5734 of 5 stars$16.74+2.8%$32.25+92.7%-3.1%$176.06M$19.86M-6.3480News CoveragePositive NewsGap UpFTLFFitLife Brands4.2179 of 5 stars$19.13+2.1%$23.00+20.2%+10.2%$175.90M$64.47M22.7720CRBUCaribou Biosciences2.8547 of 5 stars$1.81-3.2%$6.67+268.3%-13.7%$174.14M$9.99M-1.02100Positive NewsBTMDbiote2.8568 of 5 stars$3.45-0.3%$6.00+73.9%-41.1%$171.06M$197.19M3.83194News CoveragePositive NewsACTUActuate Therapeutics2.52 of 5 stars$7.94-3.6%$20.33+156.1%-12.6%$170.94MN/A0.0010BIOABioAge Labs0.2083 of 5 stars$5.09+6.9%N/AN/A$170.65MN/A0.00N/ANews CoverageTVGNTevogen Bio2.4642 of 5 stars$0.88+1.5%$10.00+1,037.4%+75.8%$170.43MN/A0.003High Trading VolumeKYTXKyverna Therapeutics2.8759 of 5 stars$3.90-1.0%$16.60+325.6%-45.7%$170.39M$7.03M-1.0696News CoveragePositive NewsNVCTNuvectis Pharma3.4727 of 5 stars$6.40-4.2%$15.33+139.6%-7.2%$170.05MN/A-5.478High Trading VolumeMCRBSeres Therapeutics3.2641 of 5 stars$22.85+18.0%$73.67+222.4%-21.5%$169.49M$126.32M-4.97330Positive NewsHigh Trading Volume Related Companies and Tools Related Companies MediWound Alternatives FitLife Brands Alternatives Caribou Biosciences Alternatives biote Alternatives Actuate Therapeutics Alternatives BioAge Labs Alternatives Tevogen Bio Alternatives Kyverna Therapeutics Alternatives Nuvectis Pharma Alternatives Seres Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JSPR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JSPR Stock Alerts